SITE SEARCH

FDA Information

The FDA approved topotecan on May 29th 1996 for the treatment of metastatic ovarian cancer, and then later in December 1998, for the treatment of small cell lung cancer.

Following this, in June 2006, topotecan in combination with cisplatin was approved for advanced cervical cancer that cannot be treated with radiation therapy or surgery. 

Please visit the official site of the FDA for further information.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose

 

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.